Clinical trial

Breast Cancer Risk Biomarkers in Postmenopausal Women

NCT01252290

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-11-01

PhasePHASE2

Study timeline

Study start (unknown)2010-11-01Date precision: month

Registry last updated2016-12-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Lovaza™DRUG

Sponsors & collaborators

Carol Fabian, MDlead sponsor

GlaxoSmithKlinecollaborator

Mapped research locations

Kansas CityKansas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01252290 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.